News Formal

UK watchdog says Cochlear's Oticon Medical deal could harm market

  • 📰 Reuters
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Britain's Competition and Markets Authority said on Thursday that Australian hearing device maker Cochlear's purchase of Demant's hearing implants business could hurt competition and mean higher prices for the National Health Service.

Demant said that irrespective of the outcome of ongoing investigations by competition authorities, it remained committed to its decision to "discontinue" its Oticon Medical as it had already concluded it had no prospect of becoming a global leader in hearing implants within a reasonable timeframe.

The deal is also under investigation by the European Union and Australian antitrust regulators, and is pending clearance under French Foreign Direct Investment rules. The CMA has set a June 5 deadline for its in-depth probe of the deal, which Cochlear said was no longer expected to close before June 30.

The regulator said the combined entity would leave only a single supplier of passive bone conductive solution products in Britain and would dominate the supply of BCS products in the country, with a share well above 90%.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 2. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Alabama Medical Cannabis Commission deems 90 applicants for medical cannabis business licenseSelect businesses in Alabama are now one step closer to potentially receiving a medical cannabis business license.
ソース: FOX10News - 🏆 581. / 51 続きを読む »